arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

TG THERAPEUTICS, INC.

TGTX

$49.55 ▼ -0.32 (-0.64%) at close

17 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Good

Bullish

auto_awesome

Analytical Summary

TG THERAPEUTICS, INC. shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $7.2B

Dividend Yield —

Revenue Growth 87.3% ↗

Op. Margin 20.0% ↗

ROIC 57.5% ↗

FCF / Share $-0.17 ↗

Trailing P/E 16.0x

Price / Book 11.9x

FCF Yield —

Debt / Equity 0.38

info Valuation on last close. End-of-day price, Aug 6, 2026.

17-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$616.29M

↑ +87.3% —

Net Income Profit after all expenses

$447.18M

↑ +1812.4% —

Operating Margin Operating profit as % of sales

20.0%

↑ +57.0% 75th

FCF / Share Free cash flow per share

$-0.17

↑ +38.0% —

Long-Term Debt Long-term obligations

$245.65M

— +0.5% —

trending_up

Bullish Indicators

Operating Margin (%)Operating Margin (%) is in the top quartile
Profit Margin (%)Profit Margin (%) is in the top quartile
Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Profitability ↑

Returns

Financial Health ↓

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Revenue Growth YoY (%)	87.3% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+991%)	40.8% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+410%)	8290.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+103525%)	-58.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-830%)	4300.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+53658%)	0.0% Caution → Caution Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-100%)	0.0% Caution Caution Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-100%)	0.0% Caution Caution Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-100%)	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	1837.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	77.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	44.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	1812.4% Excellent ↑ Excellent Improving Year-over-year change in net income	84.5% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	43.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-24.6% Weak ↑ Weak Improving Year-over-year change in net income	-61.6% Weak ↓ Weak Declining Year-over-year change in net income	0.4% Caution ↑ Caution Improving Year-over-year change in net income	-46.4% Weak ↓ Weak Declining Year-over-year change in net income	-51.4% Weak ↓ Weak Declining Year-over-year change in net income	-24.3% Weak ↑ Weak Improving Year-over-year change in net income	-12.8% Weak ↑ Weak Improving Year-over-year change in net income	-41.6% Weak ↑ Weak Improving Year-over-year change in net income	-108.2% Weak Weak Year-over-year change in net income	-2118.5% Weak Weak Year-over-year change in net income	—	—	—
FCF Growth YoY (%)	38.0% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-26.1% Weak ↓ Weak Declining Year-over-year change in free cash flow	83.0% Excellent Excellent Year-over-year change in free cash flow	41.9% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	504.9% Excellent → Excellent Stable Compound annual revenue growth over 3 years	266.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	1054.1% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	163.6% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	253.1% Excellent Excellent Compound annual revenue growth over 3 years	0.0% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	426.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	364.6% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	333.9% Excellent Excellent Compound annual revenue growth over 5 years	78.9% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Operating Margin (%) (%)	20.0% Good ↑ Good Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+33%)	12.7% Fair Fair Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-15%)	8.8% Caution Caution Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-41%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	-316.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	8.6% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	3.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	72.6% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+505%)	7.1% Caution Caution Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-41%)	5.4% Caution Caution Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-55%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	-4.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-12.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-13.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	-0.06x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-1.73x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-2.48x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	0.28x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.10x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Return on Invested Capital (%)	57.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	8.2% Fair ↑ Fair Improving Return earned on debt + equity capital invested Optimal: > 10%	7.7% Fair ↑ Fair Improving Return earned on debt + equity capital invested Optimal: > 10%	-148.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-508.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-915.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-461.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—	-141.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-7.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	11.6% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	7.3% Fair ↑ Fair Improving Operating profit relative to total assets Optimal: > 10%	6.3% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	-99.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-90.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-43.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-103.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-208.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-121.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-144.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-55.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-64.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-105.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-125.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-6.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	69.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+360%)	10.5% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-30%)	7.9% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-47%)	—	—	—	—	—	—	—	—	—	—	-121.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-911%)	-8.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-159%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Debt to Equity (x)	0.38x Good ↓ Good Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-37%)	1.10x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+83%)	0.63x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: At sector avg	1.21x Caution Caution Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+102%)	—	—	—	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	5.09x Good ↑ Good Improving Operating income divided by interest expense Optimal: > 5x	2.27x Caution ↑ Caution Improving Operating income divided by interest expense Optimal: > 5x	1.64x Caution ↑ Caution Improving Operating income divided by interest expense Optimal: > 5x	-18.92x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-61.15x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-43.23x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-31.98x Weak Weak Operating income divided by interest expense Optimal: > 5x	-198.86x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-64.95x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-59.87x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-27.20x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-30.43x Weak Weak Operating income divided by interest expense Optimal: > 5x	-124.27x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$166.50M	$64.53M	$7.47M	$-31.17M	$-231.12M	$-523.54M	$-83.67M	$-41.96M	$-56.72M	$-25.03M	$-55.06M	$-55.71M	$-40.49M	$-16.46M	$0.00	$0.00	$0.00
Debt / EBITDA (x)	1.99x Good ↓ Good Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	5.82x Weak ↑ Weak Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	4.82x Weak ↑ Weak Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.37x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.20x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.11x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.17x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Revenue per Share (USD)	$4.27	$2.26	$1.65	$0.02	$0.05	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$3.10	$0.16	$0.09	$-1.46	$-2.63	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.17	$-0.28	$-0.22	$-1.30	$-2.24	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$4.17	$1.43	$1.06	$0.40	—	—	—	—	—	—	—	—	—	$0.60	$1.90	—	—
Tangible Book Value per Share (USD)	$4.17	$1.43	$1.05	$0.39	—	—	—	—	—	—	—	—	—	$0.57	$1.74	—	—
Basic Weighted Avg Shares (shares)	144.32M	145.32M	141.96M	135.41M	132.22M	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Working Capital (USD)	$477.00M	$475.68M	$264.22M	$115.07M	$265.58M	$524.19M	$64.70M	$40.18M	$65.36M	$33.99M	$76.34M	$80.09M	$35.99M	$16.26M	$8.23M	—	—
LT Debt (USD)	$245.65M	$244.43M	$100.40M	$71.14M	$67.76M	$29.89M	$28.97M	$0.00	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$648.02M	$222.36M	$160.50M	$58.59M	—	—	—	—	—	—	—	—	—	$15.55M	$9.62M	—	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Sales/Revenue/Turnover (USD)	$616.29M	$329.00M	$233.66M	$2.79M	$6.69M	$152.00K	$152.00K	$152.00K	$152.00K	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$59.00K	$68.00K	$211.00K	$303.00K	$282.00K	$158.00K	$100.00K	$88.00K	$82.00K	$62.96K	$15.45K	$3.93K	$1.36K	$235.00	$0.00	—	—
Net Income, GAAP (USD)	$447.18M	$23.38M	$12.67M	$-198.34M	$-348.10M	$-279.38M	$-172.87M	$-173.48M	$-118.48M	$-78.25M	$-62.95M	$-55.78M	$-39.40M	$-18.93M	$-853.07K	—	—
Operating Cash Flow (USD)	$-24.77M	$-40.52M	$-31.41M	$-176.17M	$-295.63M	$-214.51M	$-132.81M	$-128.93M	—	—	—	—	—	$-5.27M	$-86.58K	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 17 years · 81 quarters

TG THERAPEUTICS, INC.

Analytical Summary

17-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare TGTX with peers